Eli Lilly (LLY): FY24 Q3 earnings call, Oct 30, 2024
No Kalshi or Polymarket word markets were listed for Eli Lilly’s Oct 30, 2024 earnings call (FY24 Q3). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
5 matches for “Medicare”; 4 quoted, at least 25 words apart.
…This offering helps even more adults living with obesity access Zepbound including Medicare beneficiaries and those without them. Slide 12, we provide an update on…
…I think pretty much where we need to be across commercial and Medicare. In terms of Zepbound, I think we've made progress in record time…
…top of that, it also opens up the door for access in Medicare, and with the decision that CMS announced back in April this year,…
…of course, the co-pay cap, out-of-pocket cap on patients, and particularly in Medicare where that could be a tailwind on the brand. I think it's…
Agents: this page as TSV at /api/v1/appearances/eli-lilly:2024-10-30:earnings_call · words: /api/v1/brief?appearance=eli-lilly:2024-10-30:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP